Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells.
about
Evaluation of the use of therapeutic peptides for cancer treatmentThe use of therapeutic peptides to target and to kill cancer cells.The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.A lipocentric view of peptide-induced pores.Mitochondria: redox metabolism and dysfunction.Molecular basis for membrane pore formation by Bax protein carboxyl terminusThyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actionsRational development of a cytotoxic peptide to trigger cell death.Targeting cancer cell mitochondria as a therapeutic approach.Targeting malignant mitochondria with therapeutic peptides.Antidepressant drugs as a complementary therapeutic strategy in cancer.Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins.Flavokawain B induces apoptosis of human oral adenoid cystic cancer ACC-2 cells via up-regulation of Bim and down-regulation of Bcl-2 expression.Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains.Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins.
P2860
Q29048586-25DE942F-7FE1-4CFE-A5CC-2EA720C0631AQ30418414-4B760B3D-5FFC-479C-A7AB-1936A962429CQ30580090-5C385E38-F89F-482D-AEBB-CB0F1B8AB75FQ34321125-78B10DCC-F7EF-4A04-97D0-B7C375A94672Q34757093-D8D3628C-B25A-475D-BD9B-26540AAF482AQ35944831-D1978CD5-3200-4FD8-8EA0-8F1723D151E4Q35955513-555013CA-36F5-4421-8944-E1705AD79B1BQ36206509-9021CED5-89A7-49C1-89AA-85F55ECE9E10Q36279284-96E4B2AF-EFB2-456F-8B65-F53080E4E0F8Q36655323-D28566B6-3342-4D68-AB1D-D39A7DB26E5DQ38040407-B10DED21-754F-4C62-957C-D674FC10D991Q38130894-69C52A4D-E1AD-4D04-90E0-DEE47BD1BEB1Q38718291-AB8ACE7F-41E7-4F7E-A05A-D0C81081E4F7Q38810383-8B4174BF-EBA7-4873-9767-100CA99A9741Q39437671-08776551-EFF1-4D0C-BF72-3D89659EACA0Q43156404-649DCFE0-560C-492E-8C63-CED2BB9CC561Q52729400-C2A5B5D2-1B8E-48EC-B1FF-0B843F0D7C0C
P2860
Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@ast
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@en
type
label
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@ast
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@en
prefLabel
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@ast
Bax-derived membrane-active pe ...... of apoptosis in cancer cells.
@en
P2093
P2860
P50
P356
P1476
Bax-derived membrane-active pe ...... s of apoptosis in cancer cells
@en
P2093
Abdel Aouacheria
Diana Gimenez
Germain Gillet
Juan Garcia Valero
Julien Prudent
Yannis Guillemin
P2860
P304
P356
10.1242/JCS.076745
P407
P577
2011-01-18T00:00:00Z